BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26318072)

  • 1. New and future strategies to improve asthma control in children.
    Anderson WC; Szefler SJ
    J Allergy Clin Immunol; 2015 Oct; 136(4):848-59. PubMed ID: 26318072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling the Risk Domain in Pediatric Asthma through Personalized Care.
    Anderson WC; Szefler SJ
    Semin Respir Crit Care Med; 2018 Feb; 39(1):36-44. PubMed ID: 29427984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe asthma in children: therapeutic considerations.
    Selby L; Saglani S
    Curr Opin Allergy Clin Immunol; 2019 Apr; 19(2):132-140. PubMed ID: 30720474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of long-acting β2-agonist in children with persistent asthma on inhaled corticosteroids.
    Ducharme FM; Gagnon R; Bénard B; Tse SM; Thivierge R
    Eur Respir J; 2016 Aug; 48(2):558-60. PubMed ID: 27230440
    [No Abstract]   [Full Text] [Related]  

  • 7. Childhood asthma: treatment update.
    Courtney AU; McCarter DF; Pollart SM
    Am Fam Physician; 2005 May; 71(10):1959-68. PubMed ID: 15926412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Asthma Outcomes: Strategies for the Future.
    Lim TK
    Ann Acad Med Singap; 2016 Dec; 45(12):532-533. PubMed ID: 28062880
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy of bronchial asthma.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic interventions to reduce the risk of asthma exacerbations.
    O'Byrne PM
    Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
    Mansfield LE
    Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology.
    Laumann JM; Bjornson DC
    Ann Pharmacother; 1998 Dec; 32(12):1290-4. PubMed ID: 9876808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
    ten Hacken NH; Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
    Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
    J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for asthma.
    Treat Guidel Med Lett; 2005 May; 3(33):33-8. PubMed ID: 15821635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corticosteroid treatment in airways narrowing].
    Chazan R
    Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy.
    Vitale C; Maglio A; Pelaia C; Vatrella A
    Expert Opin Pharmacother; 2017 May; 18(7):667-676. PubMed ID: 28387160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.